- Exploratory analysis from Phase 1b/2 breast cancer trial reinforces CD47 as a predictive biomarker for response, as previously observed in the ASPEN-06 trial in HER2-positive gastric cancer – - Full data set submitted for presentation at an upcoming scientific conference - SOUTH SAN FRANCISCO, Calif., Jan. 30, 2026 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc. (“ALX Oncology,” Nasdaq: ALXO), a clinical-stage biotechnology company advancing a pipeline of novel therapies designed to treat cancer and extend ...

Core Insights - ALX Oncology Holdings Inc. is a clinical-stage biotechnology company focused on developing novel therapies for cancer treatment and improving patient survival [3] Group 1: Company Overview - ALX Oncology is advancing a pipeline that includes its lead candidate, evorpacept, which shows promise as a cornerstone therapy in immuno-oncology [3] - The company is also developing ALX2004, an EGFR-targeted antibody-drug conjugate, currently in a Phase 1 dose-escalation trial for patients with EGFR-expressing solid tumors [3] Group 2: Upcoming Events - ALX Oncology will participate in the 44th Annual J.P. Morgan Healthcare Conference, with a corporate presentation scheduled for January 15, 2026, at 12:00 p.m. Pacific Time [1] - A live webcast of the presentation will be available on the company's website, with a replay accessible for up to 90 days post-event [2]

Group 1: Alexander's (ALX) - The company is a real estate investment trust engaged in leasing, managing, developing, and redeveloping properties [1] - The Zacks Consensus Estimate for its current year earnings has increased by 7% over the last 60 days [1] - The company has a dividend yield of 8.2%, significantly higher than the industry average of 4.8% [1] Group 2: Kforce (KFRC) - Kforce provides professional staffing services and solutions to clients on both temporary and permanent bases [2] - The Zacks Consensus Estimate for its current year earnings has increased by 3.4% over the last 60 days [2] - The company has a dividend yield of 4.9%, compared to the industry average of 2.3% [2] Group 3: BHP Group Limited (BHP) - BHP is one of the world's largest mining companies with operations in multiple countries including Australia, Brazil, Canada, Chile, Peru, and the United States [3] - The Zacks Consensus Estimate for its current year earnings has increased by 13% over the last 60 days [3] - The company has a dividend yield of 3.9%, while the industry average is 0.0% [3]

Core Viewpoint - Alexander's, Inc. has successfully restructured a $300 million mortgage loan on its retail condominium located at 731 Lexington Avenue, Manhattan, which includes a split into senior and junior notes with varying interest rates and a new maturity date [1][2]. Group 1: Loan Restructuring Details - The existing mortgage loan was divided into a $132.5 million senior "A-Note" with an interest rate of 7.00% per annum and a $167.5 million junior "C-Note" with an interest rate of 4.55% per annum, maturing on December 23, 2035 [1]. - An affiliate of Alexander's purchased the $132.5 million senior A-Note at par from the existing lenders [2]. - A new "B-Note" was established with the borrower, accruing interest at 13.5% per annum for funds used for capital and re-leasing expenses, with a different rate for amounts over $65 million used to pay interest on the A-Note [2]. Group 2: Company Overview - Alexander's, Inc. operates as a real estate investment trust (REIT) and currently owns five properties in New York City [3].

Group 1 - Alexander's, Inc. (ALX) has delivered a total return of approximately 19% in 2025, significantly outperforming the Vanguard Real Estate Index Fund ETF, which gained around 3% [1] - The investment strategy includes a focus on REITs, preferred stocks, and high-yield bonds, indicating a long-term fundamental approach to investing [1] Group 2 - The article does not provide any specific investment recommendations or advice regarding the suitability of investments for particular investors [2][3]

Core Viewpoint - Alexander's, Inc. has successfully completed a $175 million refinancing of its Rego Park II shopping center, indicating a strategic move to manage its debt and financial obligations effectively [1]. Group 1: Financial Details - The refinancing involves an interest-only loan at SOFR plus 2.00%, which currently stands at 5.82%, maturing in December 2030 [1]. - Alexander's paid down $23.5 million of the previous loan amounting to $198.5 million, which had an interest rate of SOFR plus 1.45% and was set to mature on December 12, 2025 [1]. Group 2: Company Overview - Alexander's, Inc. operates as a real estate investment trust (REIT) with a portfolio of five properties located in New York City [2].

Core Viewpoint - The article discusses a selection of stocks with high dividend yields that are currently viewed unfavorably by Wall Street analysts, suggesting potential investment opportunities in these "hated" stocks. Group 1: Real Estate Investment Trusts (REITs) - National Storage Affiliates Trust (NSA) has a yield of 7.9% and operates 1,069 properties across 37 states and Puerto Rico, benefiting from a recession-resistant business model, although it is currently facing a 20% pullback in performance [3][4] - NSA's recent quarter showed declines in earnings, core FFO, same store net operating income, and occupancy, reflecting broader challenges in the self-storage sector rather than unique issues for NSA [3][4] - Alexander's (ALX) has an 8.5% yield and is highly concentrated, with 60% of its revenues coming from tenant Bloomberg. The company is in discussions for loan restructuring after failing to repay a $300 million loan [5][6] - Despite challenges, ALX has shown double-digit total returns in 2025, outperforming the broader real estate sector, but Wall Street remains skeptical due to dividend concerns [7] Group 2: Talent Solutions and Consulting - Robert Half (RHI) has a yield of 9.0% and operates in contract talent solutions, permanent placement, and consulting services. The company has seen its stock price drop 80% since its peak in 2022, leading to more Sell and Hold ratings than Buys [10][11] - The decline in RHI's stock is attributed to a post-COVID hiring moderation, with significant job losses reported, although the company believes the impact of AI on its business is overstated [12][13] - RHI's earnings are expected to drop by 45% this year, raising concerns about dividend coverage as the payout is projected to exceed earnings through at least the end of 2026 [14] Group 3: Crafting and Creativity Platform - Cricut (CRCT) boasts a high yield of 20.6% and operates as a creativity platform, offering machines and software for crafting. The company initiated a new semiannual dividend program despite declining profits [16][17] - The stock has seen a significant decline, leading to a yield increase above 20%, with analysts recommending selling the stock [19] - Despite a loyal user base and expected profit growth of over 20% in 2025, Cricut faces challenges with flat or declining revenues projected in the coming years, particularly if economic conditions affect holiday shopping [20][21]

Core Viewpoint - The article discusses four high dividend yield stocks, ranging from 7.9% to 20.6%, that are currently being overlooked by Wall Street analysts despite their potential for income generation [1][2]. Group 1: National Storage Affiliates Trust (NSA) - NSA is a self-storage REIT with a yield of 7.9%, operating 1,069 properties across 37 states and Puerto Rico, and is considered recession-resistant [3][4]. - The stock has experienced a 20% decline in 2025, attributed to lower earnings and occupancy rates, although similar trends are seen in competitors, indicating broader industry challenges [4][5]. - NSA's payout coverage is tightening, with expected earnings of $2.20 per share against a dividend payout of $2.28, leading to concerns about sustainability [5]. Group 2: Alexanders (ALX) - ALX, yielding 8.5%, is a concentrated landlord with significant reliance on a single tenant, Bloomberg, which accounts for 60% of its revenue [6][7]. - The company is facing financial difficulties, including a loan restructuring discussion after failing to repay a $300 million loan [7]. - Despite these issues, ALX has delivered double-digit total returns in 2025, outperforming the broader real estate sector [8]. Group 3: Robert Half (RHI) - RHI has a yield of 9.0% and operates in talent solutions and consulting, but its stock has plummeted 80% since its peak in 2022, leading to more Sell and Hold ratings than Buys [10][11]. - The company is facing challenges from AI's impact on job placements, although its CEO argues that the effects are overstated for experienced roles [14][15]. - RHI's dividend payout is projected to exceed earnings significantly, with expected profits dropping by 45% this year [15]. Group 4: Cricut (CRCT) - Cricut boasts a high yield of 20.6% and operates as a creativity platform, but its profitability is declining despite recent dividend commitments [17][18]. - The company has seen a significant drop in stock price, leading to a yield increase, yet analysts are pessimistic about its future growth prospects [19][20]. - Revenue projections indicate potential stagnation or decline, particularly if economic conditions affect holiday sales, which are crucial for the company [21].

Core Insights - ALX Oncology is a clinical-stage biotechnology company focused on developing novel therapies for cancer treatment and improving patient survival [1][3] - The company will participate in two significant healthcare conferences: the Jefferies Global Healthcare Conference in London and the Piper Sandler 37th Annual Global Healthcare Conference in New York [1][2] Conference Details - Jefferies Global Healthcare Conference: - Format: Fireside Chat - Date: November 19, 2025 - Time: 11:30 AM GMT / 6:30 AM EST - Location: London, UK [2] - Piper Sandler 37th Annual Global Healthcare Conference: - Format: Fireside Chat - Date: December 3, 2025 - Time: 9:30 AM EST - Location: New York, NY [2] Company Pipeline - ALX Oncology's lead candidate, evorpacept, is positioned as a potential cornerstone therapy in immuno-oncology and is undergoing multiple clinical trials across various cancer indications [3] - The second candidate, ALX2004, is an EGFR-targeted antibody-drug conjugate that began Phase 1 trials in August 2025 [3]

Core Insights - Three stocks with strong income characteristics and buy rank are highlighted for investors to consider on November 13 Group 1: Company Performance - Alexander's, Inc. (ALX) has seen a 7% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [1] - Preferred Bank (PFBC) has experienced a 5.6% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] - Weatherford International plc (WFRD) has recorded an 8.6% increase in the Zacks Consensus Estimate for its current year earnings over the last 60 days [2] Group 2: Dividend Yield Comparison - Alexander's, Inc. (ALX) offers a dividend yield of 8%, significantly higher than the industry average of 4.8% [1] - Preferred Bank (PFBC) has a dividend yield of 3.3%, slightly above the industry average of 3.1% [2] - Another company mentioned has a dividend yield of 1.3%, compared to an industry average of 0.0% [3]